Literature DB >> 16182363

The role of methylenetetrahydrofolate reductase in acute lymphoblastic leukemia in a Brazilian mixed population.

Crisiane Wais Zanrosso1, Ana Hatagima, Mariana Emerenciano, Flávio Ramos, Alexandre Figueiredo, Têmis Maria Félix, Sandra L Segal, Roberto Giugliani, Roberto Guigliani, Maria Tereza Cartaxo Muniz, Maria S Pombo-de-Oliveira.   

Abstract

The polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene are associated with leukemogenesis. In order to investigate the influence of two polymorphisms in the MTHFR gene, 677C>T and 1298A>C, on the risk of acute lymphoblastic leukemia (ALL) we performed a case-control study in children from different Brazilians' regions. Genotyping of 176 ALL and 199 unselected healthy subjects was performed using PCR-RFLP assay. There was no association between the 677C>T or 1298A>C and risk of ALL in total case-control sample. However, 677T allele was linked to a decrease risk of ALL [odds ratio (OR), 0.43; 95% confidence interval (CI), 0.22-0.86], whereas the 1298A>C polymorphism presents an elevated risk factor [OR, 2.01; 95% CI, 1.01-3.99] in non-White children. Our investigation provides interesting data concerning the opposite effect of A1298C polymorphisms, particularly in the light of relatively scarce data regarding the MTHFR role in leukemia susceptibility in different populations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16182363     DOI: 10.1016/j.leukres.2005.08.008

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  17 in total

1.  CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome.

Authors:  Vanessa S Silveira; Renata Canalle; Carlos Alberto Scrideli; Rosane G P Queiroz; Luiz Fernando Lopes; Luiz Gonzaga Tone
Journal:  Mol Cell Biochem       Date:  2012-01-04       Impact factor: 3.396

Review 2.  Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis.

Authors:  Jayaram Vijayakrishnan; Richard S Houlston
Journal:  Haematologica       Date:  2010-05-29       Impact factor: 9.941

3.  Do polymorphisms of 5,10-methylenetetrahydrofolate reductase (MTHFR) gene affect the risk of childhood acute lymphoblastic leukemia?

Authors:  Tiago Veiga Pereira; Martina Rudnicki; Alexandre Costa Pereira; Maria S Pombo-de-Oliveira; Rendrik França Franco
Journal:  Eur J Epidemiol       Date:  2007-01-03       Impact factor: 8.082

4.  RFC-1 80G>A polymorphism in case-mother/control-mother dyads is associated with risk of nephroblastoma and neuroblastoma.

Authors:  Rafaela Montalvão-de-Azevedo; Gisele M Vasconcelos; Fernando R Vargas; Luiz Claudio Thuler; Maria S Pombo-de-Oliveira; Beatriz de Camargo
Journal:  Genet Test Mol Biomarkers       Date:  2014-12-23

5.  The methylenetetrahydrofolate reductase (MTHFR) 677 C>T polymorphism increases the risk of developing chronic myeloid leukemia-a case-control study.

Authors:  Claudia Bănescu; Mihaela Iancu; Adrian P Trifa; Ioan Macarie; Delia Dima; Minodora Dobreanu
Journal:  Tumour Biol       Date:  2014-12-16

6.  Lack of Impact of the A1298C MTHFR on the Risk of Childhood Acute Lymphoblastic Leukemia: Evidence from a Meta-analysis.

Authors:  Rim Frikha
Journal:  Indian J Hematol Blood Transfus       Date:  2021-05-26       Impact factor: 0.900

Review 7.  A literature review of MTHFR (C677T and A1298C polymorphisms) and cancer risk.

Authors:  Muzeyyen Izmirli
Journal:  Mol Biol Rep       Date:  2012-10-19       Impact factor: 2.316

Review 8.  Genetic susceptibility to childhood leukaemia.

Authors:  Anand P Chokkalingam; Patricia A Buffler
Journal:  Radiat Prot Dosimetry       Date:  2008-10-15       Impact factor: 0.972

9.  MTHFR gene polymorphism in acute lymphoblastic leukemia among North Indian children: a case-control study and meta-analysis updated from 2011.

Authors:  Nirmalya Roy Moulik; Farah Parveen; Archana Kumar; Shally Awasthi; Suraksha Agrawal
Journal:  J Hum Genet       Date:  2014-06-12       Impact factor: 3.172

10.  Methylenetetrahydrofolate reductase polymorphisms and risk of acute lymphoblastic leukemia-evidence from an updated meta-analysis including 35 studies.

Authors:  Haigang Wang; Jiali Wang; Lixia Zhao; Xinchun Liu; Wenjie Mi
Journal:  BMC Med Genet       Date:  2012-09-04       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.